64Cu-DOTATATE: Clinical Trials

5 trials of 64Cu-DOTATATE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Unknown 1
Phase 31Completed 1
Phase 41Recruiting 1

Follow 64Cu-DOTATATE: new trials by email Literature Review of 64Cu-DOTATATE trials Research Report on 64Cu-DOTATATE

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT), Photon Emission Tomography / CT (PET/CT), 64Cu-Dotatate - Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor
Phase 1CompletedUniversity of Wisconsin, Madison42025-03-072026-06-23
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography - Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2
Phase 4RecruitingVanderbilt-Ingram Cancer Center62024-05-312026-06-24
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
18F-FDG, 64Cu-Dotatate - GEP-NET, Neuroendocrine Tumors
Phase 2UnknownCopenhagen University Hospital, Rigshospitalet2002023-01-172023-11-22
64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.
64Cu-DOTATATE and 18F-FDG - Endocarditis, Endocarditis;Chronic
Not applicableCompletedEmil Loldrup Fosbol692022-04-282024-12-27
Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
64Cu-DOTATATE - Neuroendocrine Tumors
Phase 3CompletedRadiomedix, Inc.632018-08-232022-12-22

Conditions studied

Neuroendocrine Tumors (3)  ·  Carcinoma, Neuroendocrine (1)  ·  Endocarditis (1)  ·  Gastro-enteropancreatic neuroendocrine tumor (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Emil Loldrup Fosbol (1)  ·  Radiomedix, Inc. (1)  ·  University of Wisconsin, Madison (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (3)  ·  Denmark (2)

Top investigators

Andreas Kjaer, MD (1)  ·  Changhee Lee, MD (1)  ·  Ebrahim S Delpassand, MD (1)  ·  Kamran Idrees, MD (1)

Results publications

PMID 40101049